Olink

Olink®
Part of Thermo Fisher Scientific

Single-Cell and Plasma Proteomics Do Not Differentiate Patients With and Without SARS-CoV-2 Antigenemia in Convalescence in a Cohort of 100 Patients

Open Forum Infectious Diseases, 2025

Pienkos S., Swank Z., Hamlin R., Rao M., Grant P., Bonilla H., Jacobson K., Jagannathan P., Singh U., Walt D., Subramanian A., Blish C.

Disease areaApplication areaSample typeProducts
Infectious Diseases
Patient Stratification
Plasma
Olink Target 96

Olink Target 96

Abstract

Plasma samples obtained approximately 3 (n = 100) and 12 months (n = 78) after acute SARS-CoV-2 infection were tested for S1, spike, and N antigens. There were no significant differences in plasma proteins or single-cell protein expression levels on immune cells between those with and without plasma antigen detected.

Read publication ↗